Tianjin, China

Xuemin Shi

This inventor holds 1 USPTO granted patent. Top assignee: Moleac Pte Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuemin Shi. Retrieved from https://idiyas.com/inventor/xuemin-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuemin Shi - Innovator in Neurological Treatment

Introduction

Xuemin Shi is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. His innovative approach combines traditional Chinese medicine with Western medical practices.

Latest Patents

Xuemin Shi holds a patent for a groundbreaking invention titled "Combination therapy for treatment of patients with neurological disorders and cerebral infarction." This invention provides compositions and methods for treating stroke patients using traditional Chinese medicine alongside a Western medicament. His work aims to enhance the recovery process for individuals affected by strokes.

Career Highlights

Xuemin Shi is associated with Moleac Pte Ltd., a company dedicated to advancing medical treatments. His role in the company has allowed him to focus on developing innovative therapies that address critical health issues. With a total of 1 patent, his contributions are recognized within the medical community.

Collaborations

Throughout his career, Xuemin Shi has collaborated with notable professionals in the field, including David Picard and Michael Lazdunski. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in treatment methodologies.

Conclusion

Xuemin Shi's work exemplifies the integration of traditional and modern medical practices, showcasing his commitment to improving patient outcomes. His innovative patent reflects a significant step forward in the treatment of neurological disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…